CPSA Shanghai

Chemical & Pharmaceutical Structure Analysis
Where Technology and Solutions Meet. Where East Meets West.

CPSA Shanghai in Review

CPSA Shanghai 2016 Shanghai, China

Review Program

2016 Program Chair

Kelly Dong
Director, DMPK
GlaxoSmithKline, China

Plenary Lectures

Valeriu Damian-Iordache
Director, Modeling & Translational Biology
GlaxoSmithKline, USA
Quantitative Systems Pharmacology - A Key Approach to Reduce Attrition in Drug Discovery and Development

Nathan Yates
Associate Professor of Cell Biology, Department of Cell Biology
University of Pittsburgh School of Medicine, USA
Differential Mass Spectroscopy - Biomarker Discovery from Basic Research to the Clinic


CPSA Shanghai 2015 Shanghai, China

Review Program

2015 Program Chair

Philip Timmerman
Director & Research Fellow
Janssen Research & Development, Belgium

Plenary Lectures

Avijit Ghosh
Director, Mechanism Based Drug Disposition Pharmacodynamics and Metabolism
Janssen Research & Development, USA
Trends, Success Stories, and Works in Progress with Physiologically Based Pharmacokinetic Modeling: On the Optimization of Free Exposure at the Site of Action

Binodh DeSilva
Executive Director of Immunochemistry and Biomarker Development
Bristol-Myers Squibb, USA
Advances In Biologic Therapeutics Development Beyond The Era of Monoclonal Antibodies


CPSA Shanghai 2014 Shanghai, China

Review Program

2014 Program Chair

Jeff Zhang
Head of Metabolism and Pharmacokinetics
Novartis China

Plenary Lectures

Stephen Clarke
Head Drug Metabolism & Pharmacokinetics
GlaxoSmithKline
Human First Metabolism

John Yates
Professor Chemical Biology
The Scripps Research Institute
Exploring Diseases using Proteomics


CPSA Shanghai 2013 Shanghai, China

Review Program

2013 Program Chair

Naidong Weng
Scientific Director, Fellow, & Head of Bioanalytical Chemistry
Janssen Pharmaceuticals

Plenary Lectures

John Newton
Vice President and Global Head, Drug Disposition Projects, Standards and Innovation
Sanofi
The Impact of Metabolism and Pharmacokinetics in Translational Medicine: What Innovation Has Brought Us and What Challenges Still Exist?

Ian A. Blair
A.N. Richards Professor of Pharmacology
University of Pennsylvania School of Medicine
Biomarker Discovery and Validation: Challenges and Promises


CPSA Shanghai 2012 Shanghai, China

Review Program

2012 Program Chair

Jenny Zheng, Janssen

Plenary Lectures

Leslie Benet, University of California at San Francisco
Predicting Drug Disposition and Drug Dosing Parameters for New Molecular Entities

Thomas Baillie, University of Washington
Targeted Covalent Inhibitors versus Chemically-Reactive Drug Metabolites: Considerations for Rational Drug Design and Toxicological Risk Assessment


CPSA Shanghai 2011 Shanghai, China

Review Program

2011 Program Chair

Jing-Tao Wu, Millennium Pharmaceuticals

Plenary Lectures

Pete Smith, Senior Vice President, Millennium Pharmaceuticals
Challenges and Future Direction of Oncology Drug Development

Xiangmin Zhang, Fudan University
Multi-dimensional Chromatography-Mass Spectrometry for Protein Analysis

Keynote Lectures

Scott Obach, Pfizer
Stable and Reactive Metabolites in Drug Research

Lester C. Taylor, Shane Tichy, and Na Pi; Agilent Technologies
Simultaneous Determination of the PK Profile of Clozapine and its Metabolites in Rat Plasma Using a High-Resolution 6540 QTOF Instrument


CPSA Shanghai 2010 Shanghai, China

Review Program

2010 Program Chair

Yining Zhao, Ph.D., Pfizer

Plenary Lectures

Charles Tong, Global CMC, Pfizer; George Reid, Analytical R&D, Pfizer
Challenges and Opportunities of Pharmaceutical Regulatory Environment for Analytical Sciences -
An Industrial Perspective

Li Hua, The Academy of Military Medical Sciences
DMPK in Drug Discovery and Development

Keynote Lectures

John Fjeldsted, Agilent Technologies
Chip-Based Technology to Enable Biomarker Analysis

©2010 Milestone Development Services. All rights reserved.